Aptevo Therapeutics Announces $2.75M Offering Of 5,339,806 Shares Of Its Common Stock Or Pre-funded Warrants In Lieu Thereof And Warrants To Purchase Up To An Aggregate Of 10,679,612 Shares Of Its Common Stock At A Purchase Price Of $0.515 Per Share And Associated Warrant
Portfolio Pulse from Benzinga Newsdesk
Aptevo Therapeutics Inc. (NASDAQ:APVO) announced a $2.75M offering of 5,339,806 shares of its common stock or pre-funded warrants and warrants to purchase up to 10,679,612 shares at $0.515 per share. The offering is expected to close around July 1, 2024, with Roth Capital Partners and Dawson James Securities, Inc. acting as agents. The proceeds will be used for clinical development, working capital, and general corporate purposes.
June 28, 2024 | 1:23 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Aptevo Therapeutics announced a $2.75M offering of shares and warrants at $0.515 per share, expected to close by July 1, 2024. The proceeds will be used for clinical development and corporate purposes.
The offering will provide Aptevo with additional capital for its clinical development and corporate needs. However, the issuance of new shares and warrants could dilute existing shareholders, potentially neutralizing short-term price movements.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100